(Thanks to Atid-EDI) The revolutionary Ventritek105 device from Tel Aviv’s Biosan Medical treats Intra Ventricular Hemorrhage (IVH), which has a 50% average death rate. More than 90% of the study patients treated with Ventritek105 were alive and well at the 30-day follow-up.
http://www.businesswire.com/news/home/20130722005713/en/Biosan-Medical-Receives-U.S.-Patent-Device-Method